Øivind Enger

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020.

Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region.

WindSim AS develops and delivers software solutions and professional services for the wind energy industry worldwide. It offers WindSim, a wind farm design tool, which optimizes park layouts by identifying turbine locations with the highest wind speeds but with low turbulence to improve energy production while minimizing turbine load problems. The firm also offers product training, consulting, and technical support services. Its software is used by wind resource and energy assessors, meteorologists, and researchers at wind turbine manufacturers, project developers, government agencies, and academic institutions. The company was founded by Arne Reidar Gravdahl in 1993 and is headquartered in Tonsberg, Norway.

Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway.

Med Storm Innovation AS develops bio sensor systems. It develops medical software solutions for analyzing skin conductance or emotional sweating for monitoring and detecting stress/pain and awakening on patients. The company was founded by Hanne Storm on December 22, 1998 and is headquartered in Oslo, Norway.

Sorbwater Technology AS operates as a fluid environmental services company which provides technology, processes and equipment. It develops IPR and utilization of the sorbfloc product in water treatment processes which until now has been considered impossible to treat with such cross linking hydrocolloids. The firm's products are biodegradable cross linking flocculent which they have made applicable for use in almost any waste water purification treatment process regardless of chemical composition of the water and the contamination. The company was founded by Atle Mundheim Ylikangas and Asbjorn Havsgard in 2007 and is headquartered in Bergen, Norway.

Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands.

Part of Novel Diagnostics AS, Plasmacute AS is a Norwegian company that develops diagnostic sample products. The company is based in Bergen, Norway.

ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway.

UniGEO AS provides industry relevant courses in geosciences. It offers traditional courses combined with interactive learning program-GeoCLASS. Its GeoCLASS is an electronic-learning system with contents from petroleum geophysics. It also arranges geoscientific conferences on a regular basis for the purpose of connecting the bonds between students, scientists, and the oil and gas industry. The company was founded in 2007 and is headquartered in Bergen, Norway.

Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway.

Helse Bergen HF Haukeland Universitetssjukehus is a healthcare company based in Bergen, Norway. Haukeland universitetssjukehus has over 14,000 skilled employees who work every day to provide patients with high-quality specialist health services when they need them. The Norwegian company is ultimately controlled by the Government of Norway. The company was founded in 2001, and the CEO is Eivind Hansen.

Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway.

Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway.

Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway.

Part of Pfizer Inc., Pharmacia & Upjohn Co. LLC is a company that manufactures and supplies pharmaceutical goods. The company is based in Bingham Farms, MI.

Icefresh AS distributes frozen and fresh seafood products. Its processing solutions include: nitrogen freezing, storage at ultra low temperatures, and science-based method for defrosting. The firm processes pieces of skinless and boneless salmon and halibut wrapped in bite-sized portions. The company was founded by Johan Fredrik Dahle on March 28, 2006 and is headquartered in Stavanger, Norway.

Seacalx AS develops medicinal products for treatment of sea lice. Its product Qlice is used for de-licing of salmon. The firm intends to develop and sell pharmaceuticals via veterinarians to target the fish farming market. The company was founded in 2012 and is headquartered in Bergen, Norway.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

Aquiloz AS develops, produces, and trades wind power forecasting and trading information system. The company was founded by Steinar Dragsnes, Gunnar Egidius, Jensen Trond Svanes, and Rune Reisegg Jacobsen on January 17, 2011 and is headquartered in Blomsterdalen, Norway.

Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway.

J & J Future Invest AS is a Norwegian company that operates a real estate agency.